Compare AMKR & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMKR | ICLR |
|---|---|---|
| Founded | 1968 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 15.1B |
| IPO Year | 1998 | 1998 |
| Metric | AMKR | ICLR |
|---|---|---|
| Price | $51.29 | $184.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | $42.00 | ★ $202.31 |
| AVG Volume (30 Days) | ★ 4.2M | 920.7K |
| Earning Date | 02-09-2026 | 02-18-2026 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.24 | ★ 7.47 |
| Revenue | $6,449,053,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $7.49 | N/A |
| Revenue Next Year | $9.04 | $0.39 |
| P/E Ratio | $40.92 | ★ $25.15 |
| Revenue Growth | ★ 0.14 | N/A |
| 52 Week Low | $14.03 | $125.10 |
| 52 Week High | $55.17 | $211.00 |
| Indicator | AMKR | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 59.41 | 50.38 |
| Support Level | $49.00 | $183.90 |
| Resistance Level | $55.17 | $191.00 |
| Average True Range (ATR) | 3.05 | 7.17 |
| MACD | -0.27 | -0.22 |
| Stochastic Oscillator | 55.47 | 68.28 |
Amkor Technology Inc is a OSAT (outsourced semiconductor assembly and test) service provider. It has pioneered the outsourcing of integrated circuit (IC) packaging and test services and is a strategic manufacturing partner for the semiconductor companies, foundries, and electronics original equipment manufacturers (OEMs). The firm's products are organized into two categories namely advanced products that include flip chip, fine pitch bumping, wafer-level processing, advanced SiPs, power modules, and others, and Mainstream products that includes wirebond packaging and testing. The company derives maximum revenue from the advanced products category. The company derives majority of its revenue from Foreign states.
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.